The number of chondrocyte cells created and their maturation process can be influenced by multiple different genes and proteins. Two proteins,
bone morphogenetic protein 4 (BMP-4) and
fibroblast growth factor 2 (FGF2) have been seen to influence the amount of differentiation into chondrocytes. Both proteins are known to play a role in embryonic stem cell differentiation into
mesodermal cells, through signaling with BMP-4 and as FGF2 acting as a stimulator. From the mesodermal germ layer, cells will continue to differentiate down into many different types of cells. On top of BMP-4 and FGF2 stimulating the mesodermal germ layer, treatment of these proteins has also been shown to amplify the number of cells that differentiate down into chondrogenic and
osteogenic cells when cultured in chondrogenic and osteogenic mediums respectively. This process is similar across most vertebrates and is closely regulated due to the large importance of the skeleton in survival. Few deviations, misregulations, and mutations are found in organisms because they are often detrimental or lethal to the organism. This is why chondrocyte maturation is so tightly regulated. If they mature too quickly or slowly there is a large possibility the organism will not survive
gestation or infancy. One gene that is closely involved in skeletal formation is
Xylt1. Normally, this gene is responsible for catalyzing the addition of
glycosaminoglycan (GAG) side chains to
proteoglycans, which are used during cell signaling to control processes such as cell growth, proliferation, and adhesion. The two main proteoglycans that are used in this process are
heparan sulfate proteoglycans (HSPGs) and
chondroitin sulfate proteoglycans (CSPGs) which are present at high levels in the chondrocyte
extracellular matrix and are crucial in regulating chondrocyte maturation. When the GAG chain functions properly, it controls the maturation speed of chondrocytes and ensures enough cells gather in the cartilage anlage. Xylt1 is an essential gene in regards to chondrocytes and proper skeletal formation, and is a key factor in the close regulation of maturation. However, the mutation
pug of the Xylt1 gene was studied in mice in 2014 and was found to cause the pre-maturation of chondrocytes. Animals with homozygous
pug alleles display
dwarfism and have considerably shorter bones compared to
wild-type animals. Achondroplasia is either caused through a spontaneous mutation or inherited in an
autosomal dominant fashion. Both the
homozygous dominant and the
heterozygous genotypes exhibit achondroplasia symptoms, but the heterozygotes are often milder. Individuals with the mutated allele(s) display a variety of symptoms of the failure of endochondral ossification, including the shortening of
proximal long limbs and midface
hypoplasia. The non-mutated FGFR-3 gene is responsible for the expression of
fibroblast growth factors (FGFs) which has to maintain a certain level to ensure that the proliferation of chondrocytes happens accordingly. The G380R mutation causes FGFR-3 to over express FGFs and the balance within the cartilage extracellular matrix is thrown off. Chondrocytes will proliferate too quickly and disrupt the assembly at the cartilage anlage and detrimentally alter the formation of bone. This mutation acts in a dosage fashion, meaning that when only one copy is present, there is still an uptake in FGF expression, but less so than when there are two copies of the mutation. == Chondrocyte Primary Culture ==